IMOVAX POLIO DIN 01959042
Status: Marketed
Holder: SANOFI VACCINES CANADA LTD.
Molecule: POLIOVIRUS TYPE 1 MAHONEY (INACTIVATED)
Available to quote
Health Canada record
| Active ingredient(s) | POLIOVIRUS TYPE 1 MAHONEY (INACTIVATED) 29 UNIT; POLIOVIRUS TYPE 2 MEF1 (INACTIVATED) 7 UNIT; POLIOVIRUS TYPE 3 SAUKETT (INACTIVATED) 26 UNIT |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous |
| Schedule | SCHEDULE D |
| Class | Human |
| ATC | J07BF03 POLIOMYELITIS, TRIVALENT, INACTIVATED, WHOLE VIRUS |
| Original market date | 22-Mar-2007 |
| Current status date | 22-Mar-2007 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sanofi Vaccines Canada Ltd. — licence 101420, currently licensed, last inspection rating C (2026-02-23).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 7962 | 2006-05-16 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 1409 | 2000-05-01 | New Drug Submission (NDS) | |
| 5228 | 1995-02-16 | New Drug Submission (NDS) |